Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV1 in individuals with PiZZ alpha-1-antitrypsin deficiency
- 1 August 2017
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 129, 8-15
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (BMBF 01GI1001)
- Bayer/Talecris/Grifols
- Saarland University
This publication has 25 references indexed in Scilit:
- Changes in Forced Expiratory Volume in 1 Second over Time in COPDNew England Journal of Medicine, 2011
- Rate of progression of lung function impairment in α1-antitrypsin deficiencyEuropean Respiratory Journal, 2009
- Exacerbations in α1-antitrypsin deficiencyEuropean Respiratory Journal, 2005
- Smoking and Lung Function of Lung Health Study Participants after 11 YearsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in α1-Antitrypsin Deficiency and Factors Associated with DeclineAmerican Journal of Respiratory and Critical Care Medicine, 2001
- A 15-Year Follow-up Study of Ventilatory Function in Adults with AsthmaNew England Journal of Medicine, 1998
- Decline in FEV1 Among Patients With Severe Hereditary Alpha 1-Antitrypsin Deficiency Type PiZAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin PhenotypesChest, 1991
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- The natural history of chronic airflow obstruction.BMJ, 1977